Ailleurs...

FaceBook

Twitter

 

Bibliographie PDF Imprimer Envoyer
Écrit par JF. Girmens   
Vendredi, 21 Mai 2010 01:06

Argon laser photocoagulation for macular edema in branch vein occlusion.
The Branch Vein Occlusion Study Group.
Am J Ophthalmol 1984 Sep 15;98(3):271-82.

Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial.
Branch Vein Occlusion Study Group.
Arch Ophthalmol 1986 Jan;104(1):34-41.

Baseline and early natural history report. The Central Vein Occlusion Study.
Arch Ophthalmol 1993 Aug;111(8):1087-95.

Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report.
Ophthalmology 1995 Oct;102(10):1425-33.

A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report.
Ophthalmology 1995 Oct;102(10):1434-44.

Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group.
Arch Ophthalmol 1997 Apr;115(4):486-91.

Central retinal vein occlusion: what's the story?
Williamson TH.
Br J Ophthalmol 1997 Aug;81(8):698-704.

Prevalent misconceptions about acute retinal vascular occlusive disorders.
Hayreh SS.
Prog Retin Eye Res 2005 Jul;24(4):493-519.

Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors.
Janssen MC, den Heijer M, Cruysberg JR, Wollersheim H, Bredie SJ.
Thromb Haemost 2005 Jun;93(6):1021-6.

Occlusions veineuses rétiniennes.
Paques M.
EMC (Elsevier Masson SAS, Paris) Ophtalmologie 2007: 21-240-E-15.

Interventions for branch retinal vein occlusion: an evidence-based systematic review.
McIntosh RL, Mohamed Q, Saw SM, Wong TY.
Ophthalmology 2007 May;114(5):835-54. Epub 2007 Mar 30.

Interventions for central retinal vein occlusion: an evidence-based systematic review.
Mohamed Q, McIntosh RL, Saw SM, Wong TY.
Ophthalmology 2007 Mar;114(3):507-19, 524.

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5.
Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Singerman LJ, Tolentino M, Chan CK, Gonzalez VH; SCORE Study Research Group.
Arch Ophthalmol 2009 Sep;127(9):1101-14. Erratum in: Arch Ophthalmol. 2009 Dec;127(12):1648.

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.
Scott IU, Ip MS, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Chan CK, Gonzalez VH, Singerman LJ, Tolentino M; SCORE Study Research Group.
Arch Ophthalmol 2009 Sep;127(9):1115-28. Erratum in: Arch Ophthalmol. 2009 Dec;127(12):1655.

The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia.
Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, Kowalski JW, Nguyen H, Wong TY; International Eye Disease Consortium.
Ophthalmology 2010 Feb;117(2):313-9.e1.

Ranibizumab for Macular Edema following Central Retinal Vein Occlusion Six-Month Primary End Point Results of a Phase III Study.
Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, Rundle AC, Rubio RG, Murahashi WY; CRUISE Investigators.
Ophthalmology 2010 Apr 8. [Epub ahead of print]

Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion Six-Month Primary End Point Results of a Phase III Study.
Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC, Murahashi WY, Rubio RG; BRAVO Investigators.
Ophthalmology 2010 Apr 14. [Epub ahead of print]

Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion.
Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; OZURDEX GENEVA Study Group.
Ophthalmology 2010 Apr 22. [Epub ahead of print]

Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.
Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM; Ozurdex GENEVA Study Group, Li J.
Ophthalmology 2011 Dec;118(12):2453-60. doi: 10.1016/j.ophtha.2011.05.014. Epub 2011 Jul 20.

Central retinal vein occlusion: a review.
McAllister IL.
Clin Experiment Ophthalmol 2012 Jan-Feb;40(1):48-58. doi: 10.1111/j.1442-9071.2011.02713.x. Epub 2011 Dec 6.

Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial.
Heier JS, Campochiaro PA, Yau L, Li Z, Saroj N, Rubio RG, Lai P.
Ophthalmology. 2012 Apr;119(4):802-9. doi: 10.1016/j.ophtha.2011.12.005. Epub 2012 Feb 1.

Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study.
Boyer D, Heier J, Brown DM, Clark WL, Vitti R, Berliner AJ, Groetzbach G, Zeitz O, Sandbrink R, Zhu X, Beckmann K, Haller JA.
Ophthalmology 2012 May;119(5):1024-32. doi: 10.1016/j.ophtha.2012.01.042. Epub 2012 Mar 21.

VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO study.
Holz FG, Roider J, Ogura Y, Korobelnik JF, Simader C, Groetzbach G, Vitti R, Berliner AJ, Hiemeyer F, Beckmann K, Zeitz O, Sandbrink R.
Br J Ophthalmol 2013 Mar;97(3):278-84. doi: 10.1136/bjophthalmol-2012-301504. Epub 2013 Jan 7.

Mise à jour le Jeudi, 28 Mars 2013 02:32
 
Joomla Templates by Joomlashack